Mechanisms of Resistance to PARP Inhibitor and Strategies to Improve Its Sensitivity in Epithelial Ovarian Cancer
ZHANG Wen-yang
Keywords：Poly (ADP-ribose) polymerase inhibitorsOvarian neoplasmsNeoplasmsglandular and epithelialHomologous recombinationGenesBRCA1BRCA2Drug therapy
Publication Date：2024-02-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：8( 52-59 )